BRPI0418273A - imunógenos alvejados - Google Patents
imunógenos alvejadosInfo
- Publication number
- BRPI0418273A BRPI0418273A BRPI0418273-1A BRPI0418273A BRPI0418273A BR PI0418273 A BRPI0418273 A BR PI0418273A BR PI0418273 A BRPI0418273 A BR PI0418273A BR PI0418273 A BRPI0418273 A BR PI0418273A
- Authority
- BR
- Brazil
- Prior art keywords
- immunogens
- immunogen
- reagents
- targeted
- enhanced
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000007236 host immunity Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53372803P | 2003-12-31 | 2003-12-31 | |
| PCT/US2004/044023 WO2005066203A2 (en) | 2003-12-31 | 2004-12-30 | Targeted immunogens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0418273A true BRPI0418273A (pt) | 2007-05-02 |
Family
ID=34748948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0418273-1A BRPI0418273A (pt) | 2003-12-31 | 2004-12-30 | imunógenos alvejados |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060002946A1 (enExample) |
| EP (1) | EP1699492A2 (enExample) |
| JP (1) | JP2007536911A (enExample) |
| KR (1) | KR20060129353A (enExample) |
| CN (1) | CN1921889A (enExample) |
| AU (1) | AU2004312548A1 (enExample) |
| BR (1) | BRPI0418273A (enExample) |
| CA (1) | CA2552251A1 (enExample) |
| IL (1) | IL176603A0 (enExample) |
| MX (1) | MXPA06007574A (enExample) |
| WO (1) | WO2005066203A2 (enExample) |
| ZA (1) | ZA200605304B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0103110D0 (en) * | 2000-08-25 | 2001-03-28 | Aventis Pharma Inc | A membrane penetrating peptide encoded by a nuclear localization sequence from human period 1 |
| WO2012123755A1 (en) | 2011-03-17 | 2012-09-20 | The University Of Birmingham | Re-directed immunotherapy |
| KR20170116039A (ko) * | 2015-02-18 | 2017-10-18 | 에프. 호프만-라 로슈 아게 | 표적 세포에 대항하여 t 세포 세포독성을 특이적으로 유도하기 위한 면역컨주게이트 |
| CA2984629C (en) | 2015-05-07 | 2024-06-18 | University Of South Florida | Modified ube3a gene for a gene therapy approach for angelman syndrome |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE391791T1 (de) * | 2000-08-25 | 2008-04-15 | Aventis Pharma Inc | Membran penetrierende peptide und deren anwendungen |
| CA2477429A1 (en) * | 2002-01-29 | 2003-08-07 | Robert A. Uger | Targeted immunogens |
-
2004
- 2004-12-30 AU AU2004312548A patent/AU2004312548A1/en not_active Abandoned
- 2004-12-30 MX MXPA06007574A patent/MXPA06007574A/es unknown
- 2004-12-30 BR BRPI0418273-1A patent/BRPI0418273A/pt not_active IP Right Cessation
- 2004-12-30 US US11/026,403 patent/US20060002946A1/en not_active Abandoned
- 2004-12-30 WO PCT/US2004/044023 patent/WO2005066203A2/en not_active Ceased
- 2004-12-30 CA CA002552251A patent/CA2552251A1/en not_active Abandoned
- 2004-12-30 CN CNA2004800421537A patent/CN1921889A/zh active Pending
- 2004-12-30 JP JP2006547589A patent/JP2007536911A/ja not_active Abandoned
- 2004-12-30 KR KR1020067015438A patent/KR20060129353A/ko not_active Withdrawn
- 2004-12-30 EP EP04816007A patent/EP1699492A2/en not_active Withdrawn
-
2006
- 2006-06-27 ZA ZA200605304A patent/ZA200605304B/en unknown
- 2006-06-28 IL IL176603A patent/IL176603A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005066203A2 (en) | 2005-07-21 |
| IL176603A0 (en) | 2006-10-31 |
| US20060002946A1 (en) | 2006-01-05 |
| CN1921889A (zh) | 2007-02-28 |
| WO2005066203A3 (en) | 2005-09-01 |
| JP2007536911A (ja) | 2007-12-20 |
| EP1699492A2 (en) | 2006-09-13 |
| MXPA06007574A (es) | 2007-04-17 |
| KR20060129353A (ko) | 2006-12-15 |
| AU2004312548A1 (en) | 2005-07-21 |
| CA2552251A1 (en) | 2005-07-21 |
| ZA200605304B (en) | 2007-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR9512A (es) | Metodos para el tratamiento de tumores de cerebro con anticuerpos | |
| CY1122117T1 (el) | Ενεργοποιηση μιας ανοσοαποκρισης | |
| BRPI0418317A (pt) | vacina de aumento de crescimento à base de epitopo de neutralização | |
| BRPI0510430A (pt) | composições e métodos para vacinação mucosal | |
| BR122018016045B8 (pt) | proteína variante otimizada | |
| CY1108937T1 (el) | Χρηση της κινασης πρωτεϊνης ν-β | |
| BRPI0314814C1 (pt) | anticorpo compreendendo uma variante de fc | |
| MX2010008633A (es) | Ruptura de tolerancia inmunologica con un aminoacido no natural geneticamente codificado. | |
| BRPI0509819A (pt) | integração de marca d' água | |
| BR112023023671A2 (pt) | Composições imunogênicas compreendendo antígenos de sacarídeo capsular conjugados e usos dos mesmos | |
| BRPI0516323A (pt) | construtos de rna | |
| CY1118492T1 (el) | Φαρμακοτεχνικες μορφες εμβολιου norovirus | |
| BRPI0817299A8 (pt) | vacinas e componentes de vacina para inibição de células microbianas | |
| GB2473782A (en) | Luminescent cycle regulator and fertility indicator | |
| BR0214457A (pt) | métodos para o tratamento de cáncer | |
| BR112014020697A2 (pt) | anticorpo modificado compreendendo um motivo contendo cisteína na terminação do anticorpo, conjugado anticorpo-droga modificado compreendendo uma droga ligada ao anticorpo modificado e método de produção do mesmo | |
| TW200801042A (en) | Anti-CTLA-4 antibody and CpG-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment | |
| TW200719910A (en) | C. perfringens alpha toxoid vaccine | |
| BRPI0406800A (pt) | Peptìdio dimerizado | |
| FI20065385A7 (fi) | Luunkiinnitysväline | |
| BR0312856A (pt) | Aditivo de solo e método para produção do mesmo | |
| BR112018017174A2 (pt) | conjugados de aminoácido e peptídeo e processo de conjugação | |
| BR9915732A (pt) | Geração de anticorpos usando-se vacinação de polinucleotìdeo em espécie de ave | |
| BR112013030124A2 (pt) | conjunto direcionador ajustável | |
| MXPA03004986A (es) | Proceso para preparar polimeros de emulsion con alta pureza. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: C07K 14/47 (2006.01), A61K 39/00 (2006.01) |